Human papillomavirus prevalence in oral potentially malignant disorders: Systematic review and meta‐analysis von Cour, Cecilie D., Sperling, Cecilie D., Belmonte, Federica, Syrjänen, Stina, Kjaer, Susanne K.

Volltext

Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study von Sperling, Cecilie D., Verdoodt, Freija, Kjær Hansen, Merete, Dehlendorff, Christian, Friis, Søren, Kjaer, Susanne K.

Volltext

Use of antidepressants and endometrial-cancer risk: a nationwide nested case–control study von Sperling, Cecilie D, Aalborg, Gitte L, Dehlendorff, Christian, Friis, Søren, Mørch, Lina S, Kjaer, Susanne K

Volltext

Low-dose aspirin use and endometrial cancer mortality—a Danish nationwide cohort study von Sperling, Cecilie D, Verdoodt, Freija, Aalborg, Gitte L, Dehlendorff, Christian, Friis, Søren, Kjaer, Susanne K

Volltext

Statin use and risk of endometrial cancer: a nationwide registry‐based case–control study von Sperling, Cecilie D., Verdoodt, Freija, Friis, Søren, Dehlendorff, Christian, Kjaer, Susanne K.

Volltext

Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures (S47.007) von Ashina, Messoud, Lipton, Richard B., Ailani, Jessica, Versijpt, Jan, Sacco, Simona, Mitsikostas, Dimos D., Christoffersen, Cecilie, Sperling, Bjorn, Ettrup, Anders

Volltext

Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial von Ashina, Messoud, Lipton, Richard B., Ailani, Jessica, Versijpt, Jan, Sacco, Simona, Mitsikostas, Dimos D., Christoffersen, Cecilie Laurberg, Sperling, Bjørn, Ettrup, Anders

Volltext

Eptinezumab dans la prophylaxie de la migraine chez les patients en échec à 2–4 traitements antérieurs : analyse en sous population de l’étude DELIVER von Ashina, Messoud, Lanteri-Minet, Michel, Pozo-Rosich, Patricia, Ettrup, Anders, Laurberg Christoffersen, Cecilie, Sperling, Bjørn, Defawe Rajca, Caroline

Volltext

Impact de l’eptinezumab sur les résultats rapportés par le patient (PRO) chez des patients migraineux en échec aux traitements préventifs antérieurs von Goadsby, Peter, Barbanti, Piero, Ettrup, Anders, Laurberg Christoffersen, Cecilie, Josiassen, Mette Krog, Sperling, Bjørn, Defawe Rajca, Caroline

Volltext